{
  "trial_id": "NCT02209857",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Oestrogen receptor positive",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Invasive ductal breast cancer",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Female breast cancer patients",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Benefit of adjuvant chemotherapy is uncertain based on traditional prognostic factors",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Written informed consent",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Multicentric or contralateral disease",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous history of malignancy (in the five years before breast cancer diagnosis)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Confirmed distant metastasis",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "Neoadjuvant systemic treatment",
      "label": "does_not_trigger",
      "evidence": "patient text"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT02209857",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}